Vor Biopharma Inc.
VOR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76 | $151 | $263 | $432 |
| - Cash | $82 | $31 | $58 | $120 |
| + Debt | $32 | $36 | $39 | $18 |
| Enterprise Value | $26 | $155 | $244 | $330 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$3 | -$9 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$118 | -$114 | -$83 | -$68 |
| % Margin | – | – | – | – |
| Net Income | -$117 | -$118 | -$92 | -$69 |
| % Margin | – | – | – | – |
| EPS Diluted | -34 | -35 | -46.6 | -37.8 |
| % Growth | 2.9% | 24.9% | -23.3% | – |
| Operating Cash Flow | -$100 | -$100 | -$85 | -$69 |
| Capital Expenditures | -$0 | -$1 | -$8 | -$4 |
| Free Cash Flow | -$100 | -$101 | -$94 | -$73 |